Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Tissot

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Free Radical Biology & Medicine|March 24, 2009
Enhanced leukocyte HIF-1alpha and HIF-1 DNA binding in humans after rapid ascent to 4300 mMartha C Tissot van Patot, Natalie J Serkova, Manuel Haschke, et al.
IEEE Journal of Biomedical and Health Informatics|March 10, 2020
Natural Language Processing for Mimicking Clinical Trial Recruitment in Critical Care: A Semi-Automated Simulation Based on the LeoPARDS TrialHegler C Tissot, Anoop D Shah, David Brealey, et al.
Revue Medicale Suisse|April 29, 2015
[Congenital heart disease: from childhood to adulthood]N Sekarski, J Bouchardy, T Rutz, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|October 30, 2009
Human placental metabolic adaptation to chronic hypoxia, high altitude: hypoxic preconditioningMartha C Tissot van Patot, Andrew J Murray, Virginia Beckey, et al.
Lancet (London, England)|March 11, 2008
Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa studyAlain C Tissot, Patrik Maurer, Juerg Nussberger, et al.
Neuron|January 14, 2014
Increased brain penetration and potency of a therapeutic antibody using a monovalent molecular shuttleJens Niewoehner, Bernd Bohrmann, Ludovic Collin, et al.
European Journal of Immunology|December 21, 2012
A VLP-based vaccine against interleukin-1α protects mice from atherosclerosisAlain C Tissot, Gunther Spohn, Gary T Jennings, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 24, 2011
The second-generation active Aβ immunotherapy CAD106 reduces amyloid accumulation in APP transgenic mice while minimizing potential side effectsChristoph Wiessner, Karl-Heinz Wiederhold, Alain C Tissot, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 11, 2014
Combined inhibition of tumor necrosis factor α and interleukin-17 as a therapeutic opportunity in rheumatoid arthritis: development and characterization of a novel bispecific antibodyJens A A Fischer, Axel J Hueber, Stacy Wilson, et al.
Free Radical Biology & Medicine|April 11, 2009
A potential role for reactive oxygen species and the HIF-1alpha-VEGF pathway in hypoxia-induced pulmonary vascular leakDavid C Irwin, Joe M McCord, Eva Nozik-Grayck, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Free Radical Biology & Medicine|March 24, 2009
Enhanced leukocyte HIF-1alpha and HIF-1 DNA binding in humans after rapid ascent to 4300 mMartha C Tissot van Patot, Natalie J Serkova, Manuel Haschke, et al.
IEEE Journal of Biomedical and Health Informatics|March 10, 2020
Natural Language Processing for Mimicking Clinical Trial Recruitment in Critical Care: A Semi-Automated Simulation Based on the LeoPARDS TrialHegler C Tissot, Anoop D Shah, David Brealey, et al.
Revue Medicale Suisse|April 29, 2015
[Congenital heart disease: from childhood to adulthood]N Sekarski, J Bouchardy, T Rutz, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|October 30, 2009
Human placental metabolic adaptation to chronic hypoxia, high altitude: hypoxic preconditioningMartha C Tissot van Patot, Andrew J Murray, Virginia Beckey, et al.
Lancet (London, England)|March 11, 2008
Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa studyAlain C Tissot, Patrik Maurer, Juerg Nussberger, et al.
Neuron|January 14, 2014
Increased brain penetration and potency of a therapeutic antibody using a monovalent molecular shuttleJens Niewoehner, Bernd Bohrmann, Ludovic Collin, et al.
European Journal of Immunology|December 21, 2012
A VLP-based vaccine against interleukin-1α protects mice from atherosclerosisAlain C Tissot, Gunther Spohn, Gary T Jennings, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 24, 2011
The second-generation active Aβ immunotherapy CAD106 reduces amyloid accumulation in APP transgenic mice while minimizing potential side effectsChristoph Wiessner, Karl-Heinz Wiederhold, Alain C Tissot, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 11, 2014
Combined inhibition of tumor necrosis factor α and interleukin-17 as a therapeutic opportunity in rheumatoid arthritis: development and characterization of a novel bispecific antibodyJens A A Fischer, Axel J Hueber, Stacy Wilson, et al.
Free Radical Biology & Medicine|April 11, 2009
A potential role for reactive oxygen species and the HIF-1alpha-VEGF pathway in hypoxia-induced pulmonary vascular leakDavid C Irwin, Joe M McCord, Eva Nozik-Grayck, et al.
Pageof 7